Publication | Open Access

Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells

Tumour-specific Mhc-class-ii-restricted ResponsesCancer ImmunosurveillanceAnnexin IiImmunologyTumor ImmunityImmune Checkpoint InhibitorAntigen ProcessingMelanoma CellsImmunotherapyMedicineCell BiologyTumor MicroenvironmentCancer ResearchSynthetic Immunology